Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Raises EPS, Revenue Guidance as Phadia Purchase Closes

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today raised its adjusted EPS and revenues guidance for full-year 2011 following the completion of its purchase of specialty diagnostics firm Phadia.

Thermo Fisher announced that its $3.5 billion purchase of the firm had closed and said that the acquisition is expected to contribute $.07 to full-year EPS, a $.01 increase from an original estimate of $.06, excluding restructuring, amortization of acquisition-related intangible assets, and other gains and costs.

As a result, it raised adjusted EPS guidance to a new range of between $4.15 and $4.25, which would represent a 20 percent to 23 percent increase over 2010 EPS. During its recent second-quarter earnings release, Thermo Fisher had given adjusted EPS guidance of between $4.08 and $4.18.

Phadia is also expected to contribute $190 million in revenues to Thermo Fisher for the year, and as a result the company raised its revenue guidance to a new range of $11.79 billion to $11.89 billion, which would represent around 12 percent growth over 2010.

Thermo Fisher had given guidance of between $11.60 billion to $11.70 billion last month.

Based in Uppsala, Sweden, Phadia has 1,500 employees worldwide and generated €367 ($529.5 million) in revenues in 2010. Phadia will become part of Thermo Fisher's Specialty Diagnostics business.

Following Thermo Fisher's announcement, Jon Wood of investment bank Jefferies raised his full-year 2011 EPS and revenue estimates for the company to $4.22 and $11.9 billion, respectively. He previously had estimated EPS of $4.15 on revenues of $11.7 billion.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.